Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

被引:37
|
作者
Sun, Yating [1 ]
Zhao, Yarong [1 ]
Zhao, Xiuting [1 ]
Lee, Robert J. [1 ,2 ]
Teng, Lesheng [1 ]
Zhou, Chenguang [3 ]
机构
[1] Jilin Univ, Sch Life Sci, Changchun 130012, Jilin, Peoples R China
[2] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[3] Tavistock Life Sci, San Diego, CA 92130 USA
关键词
oligonucleotide; siRNA; miRNA; antisense; nanocarriers; TYROSINE KINASE INHIBITOR; SIRNA DELIVERY; IN-VITRO; ANTISENSE OLIGONUCLEOTIDES; CO-DELIVERY; POLYMERIC NANOPARTICLES; INTRACELLULAR DELIVERY; LOADED NANOBUBBLES; GOLD NANOPARTICLES; TARGETED DELIVERY;
D O I
10.3390/molecules22101724
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligonucleotide (ON) drugs, including small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotides, are promising therapeutic agents. However, their low membrane permeability and sensitivity to nucleases present challenges to in vivo delivery. Chemical modifications of the ON offer a potential solution to improve the stability and efficacy of ON drugs. Combined with nanoparticle encapsulation, delivery at the site of action and gene silencing activity of chemically modified ON drugs can be further enhanced. In the present review, several types of ON drugs, selection of chemical modification, and nanoparticle-based delivery systems to deliver these ON drugs are discussed.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Enhancing the Drug Encapsulation Efficiency of Liposomes for Therapeutic Delivery
    Roberts, Steven A.
    Agrawal, Nitin
    2017 IEEE-NIH HEALTHCARE INNOVATIONS AND POINT OF CARE TECHNOLOGIES (HI-POCT), 2017, : 136 - 139
  • [2] Chemical Modification of Oligonucleotides for Therapeutic, Bioanalytical and other Applications
    Bell, Neil M.
    Micklefield, Jason
    CHEMBIOCHEM, 2009, 10 (17) : 2691 - 2703
  • [3] The delivery of therapeutic oligonucleotides
    Juliano, Rudolph L.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (14) : 6518 - 6548
  • [4] Delivery of therapeutic oligonucleotides in nanoscale
    Wu, Lei
    Zhou, Wenhui
    Lin, Lihua
    Chen, Anhong
    Feng, Jing
    Qu, Xiangmeng
    Zhang, Hongbo
    Yue, Jun
    BIOACTIVE MATERIALS, 2022, 7 : 292 - 323
  • [5] Intercellular delivery of therapeutic oligonucleotides
    Valiunas, Virginijus
    Gordon, Chris
    Valiuniene, Laima
    Devine, Daniel
    Lin, Richard Z.
    Cohen, Ira S.
    Brink, Peter R.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 72
  • [6] Nanoparticle stabilized capsules for encapsulation and delivery
    Jeong, Youngdo
    Rotello, Vincent Martin
    Samata, Bappaditya
    Agasti, Sarit
    Yang, Xiao-chao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [7] Encapsulation and Delivery of Therapeutic Phages
    Loh, Belinda
    Gondil, Vijay Singh
    Manohar, Prasanth
    Khan, Fazal Mehmood
    Yang, Hang
    Leptihn, Sebastian
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2021, 87 (05) : 1 - 13
  • [8] Bioconjugates for targeted delivery of therapeutic oligonucleotides
    Ming, Xin
    Laing, Brian
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 81 - 89
  • [9] Drug delivery system of therapeutic oligonucleotides
    Asami, Yutaro
    Yoshioka, Kotaro
    Nishina, Kazutaka
    Nagata, Tetsuya
    Yokota, Takanori
    DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (05): : 256 - 262
  • [10] Chemical modification of antisense oligonucleotides.
    Wang, SQ
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1995, 22 (06) : 506 - 511